Connection
Larry Moreland to Cyclooxygenase Inhibitors
This is a "connection" page, showing publications Larry Moreland has written about Cyclooxygenase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.315 |
|
|
|
-
Osiri M, Moreland LW. Specific cyclooxygenase 2 inhibitors: a new choice of nonsteroidal anti-inflammatory drug therapy. Arthritis Care Res. 1999 Oct; 12(5):351-62.
Score: 0.169
-
Patino FG, Allison J, Olivieri J, Mudano A, Juarez L, Person S, Mikuls TR, Moreland L, Kovac SH, Saag KG. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs. Arthritis Rheum. 2003 Jun 15; 49(3):293-9.
Score: 0.055
-
Misischia RJ, Moreland LW. Rheumatoid arthritis: developing pharmacological therapies. Expert Opin Investig Drugs. 2002 Jul; 11(7):927-35.
Score: 0.051
-
Moreland LW, St Clair EW. The use of analgesics in the management of pain in rheumatic diseases. Rheum Dis Clin North Am. 1999 Feb; 25(1):153-91, vii.
Score: 0.040